A Research Study Comparing a New Medicine Oral Semaglutide to Placebo in People With Type 2 Diabetes

Clinical trial NCT04109547 · COMPLETED

Trial details

NCT number: NCT04109547
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2

Start date: 2019-10-01
Primary completion: 2021-09-23
Enrollment: 521

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.